OpenFilings
Inmune Bio, Inc.
Form
8-K
Report Period
2026-06-16
Date Filed
2026-06-17
Time Filed
16:01:15
Document Analysis
Natural Language Processing
Recognized Type
Unidentified
Defined Term Format
Underlined
Italicized
Bold
Exhibits
CURRENT REPORT
THIRD AMENDED AND RESTATED INMUNE BIO INC. 2021 STOCK INCENTIVE PLAN
Filing on SEC Edgar